Vident Advisory’s Avanos Medical AVNS Stock Holding History

Vident Advisory’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-16,687	Closed	-$234K	–	1938
2026 Q1	$234K	Sell	16,687 -35,362	-68%	-$476K	﹤0.01%	1612
2025 Q4	$585K	Buy	+52,049	New	+$596K	0.01%	1086

Other funds holding AVNS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

NAM

Nexpoint Asset Management Dallas, Texas $1.5B AUM 83.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

TAL

TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

FTCM

First Trust Capital Management Chicago, Illinois $1.72B AUM 70.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vident Advisory's AVNS Position: Q2 2026 in Review

Vident Advisory sold out of Avanos Medical (AVNS) in Q2 2026, closing a stake of 16,687 shares — an estimated $234K sold.

Vident Advisory first reported a position in AVNS in Q4 2025 and held it in 2 quarters. The position peaked at $585K in Q4 2025. 286 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

Vident Advisory reported no remaining Avanos Medical position as of Q2 2026 after selling out during the quarter.
Vident Advisory sold 16,687 Avanos Medical shares in Q2 2026, an estimated $234K.
Vident Advisory first reported a position in Avanos Medical in Q4 2025 and held it in 2 quarters.
Vident Advisory's Avanos Medical position peaked at $585K in Q4 2025.
286 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on Vident Advisory's 13F filing for Q2 2026, filed 12 Aug 2026.